BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32216738)

  • 1. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
    Maiese K
    Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights for Oxidative Stress and Diabetes Mellitus.
    Maiese K
    Oxid Med Cell Longev; 2015; 2015():875961. PubMed ID: 26064426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease.
    Maiese K
    J Transl Sci; 2016; 1(3):83-85. PubMed ID: 26893943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
    Maiese K
    Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasis.
    Yaribeygi H; Atkin SL; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(10):16966-16970. PubMed ID: 30807659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
    Maiese K
    Curr Neurovasc Res; 2017; 14(1):82-88. PubMed ID: 27897112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1.
    Wang S; Chong ZZ; Shang YC; Maiese K
    Curr Neurovasc Res; 2013 Feb; 10(1):54-69. PubMed ID: 23151077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
    Deng W; Fernandez A; McLaughlin SL; Klinke DJ
    J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WISP1: Clinical insights for a proliferative and restorative member of the CCN family.
    Maiese K
    Curr Neurovasc Res; 2014; 11(4):378-89. PubMed ID: 25219658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programming apoptosis and autophagy with novel approaches for diabetes mellitus.
    Maiese K
    Curr Neurovasc Res; 2015; 12(2):173-88. PubMed ID: 25742566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
    Maiese K
    Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead transcription factors: new considerations for alzheimer's disease and dementia.
    Maiese K
    J Transl Sci; 2016 Jul; 2(4):241-247. PubMed ID: 27390624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy.
    Wang S; Chong ZZ; Shang YC; Maiese K
    Curr Neurovasc Res; 2012 May; 9(2):91-101. PubMed ID: 22475393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL.
    Wang S; Chong ZZ; Shang YC; Maiese K
    Curr Neurovasc Res; 2012 Feb; 9(1):20-31. PubMed ID: 22272766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease.
    Maiese K
    Neural Regen Res; 2015 Apr; 10(4):518-28. PubMed ID: 26170801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WISP1 is a novel adipokine linked to inflammation in obesity.
    Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
    Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2015; 12(4):404-13. PubMed ID: 26256004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
    Gurbuz I; Chiquet-Ehrismann R
    Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
    Maiese K
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.